Journal of the Neurological Sciences
Volume 206, Issue 1 , Pages 85-90 , 15 January 2003

Conditions of iodine contrast transfer from lumbosacral CSF to blood

  • Sepp Seyfert

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +49-30-8445-2276; fax: +49-30-8445-4264.
    • Department of Neurology, University Hospital Benjamin Franklin, Free University of Berlin, Berlin D-12200, Germany
    • ,
  • Hans Christian Koch

      Affiliations

    • Department of Radiology, University Hospital Benjamin Franklin, Free University of Berlin, Berlin, Germany
    • ,
  • Volker Kunzmann

      Affiliations

    • Department of Neurology, University Hospital Benjamin Franklin, Free University of Berlin, Berlin D-12200, Germany

Received 5 March 2002 ,Revised 5 August 2002 ,Accepted 28 August 2002.

References 

  1. Golman K. Absorption of metrizamide from cerebrospinal fluid to blood: pharmacokinetics in humans. J. Pharm. Sci. 1975;64:405–407
  2. Speck U, Schmidt R, Volkhardt V, Vogelsang H. The effect of position of patient on the passage of metrizamide (Amipaque), meglumine iocarmate (Dimer X) and ioserinate (Myelografin) into the blood after lumbar myelography. Neuroradiology. 1978;14:251–256
  3. Duchin KL, Drayer BP, Ross M, Allen S, Frantz M. Pharmacokinetics of iopamidol after intrathecal administration in humans. AJNR. 1986;7:895–898
  4. Kugoev AI, Krause W, Timerbaeva SL, Wegener R. Pharmacokinetics and tolerability of iopromide 240 after lumbar myelography. Invest. Radiol. 1999;34:692–697
  5. DiChiro G. Movement of the cerebrospinal fluid in human beings. Nature. 1964;204:290–291
  6. Kieffer SA, Wolff JM, Prentice WB, Loken MK. Scinticisternography in individuals without known neurological disease. Am. J. Roentgenol. 1971;112:225–236
  7. Eldevik OP. Elimination of metrizamide from the spinal subarachnoid space: a study of patients with abolished intracranial circulation. AJNR. 1983;4:585–587
  8. Solutrast®-Iopamidol. manufacturer's manual. Konstanz: BYK-Gulden; 2000;
  9. Reiber H, Peter JB. Cerebrospinal fluid analysis: disease-related data patterns and evaluation programs. J. Neurol. Sci. 2001;84:101–122
  10. Olkin I, Siotani M. Testing for the equality of correlation coefficients for various multivariate models. Technical report. Stanford University: Laboratory for Quantitative Research in Education, 1964.
  11. Reiber H. Flow rate of cerebrospinal fluid (CSF)—a concept common to normal blood–CSF barrier function and to dysfunction in neurological diseases. J. Neurol. Sci. 1994;122:189–203
  12. Blennow K, Fredman P, Wallin A, Gottfries CG, Karlsson I, Langström G, et al.  Protein analysis in cerebrospinal fluid. Eur. Neurol. 1993;33:129–133
  13. Gomez DG, Chambers AA, Di Benedetto AT, Potts DG. The spinal cerebrospinal fluid absorptive pathways. Neuroradiology. 1974;8:61–66
  14. Kido DK, Gomez DG, Pavese AM, Potts DG. Human spinal arachnoid villi and granulations. Neuroradiology. 1976;11:221–228
  15. Upton ML, Weller RO. The morphology of cerebrospinal fluid drainage pathways in human arachnoid granulations. J. Neurosurg. 1985;63:67–75
  16. Bozanovic-Sosic R, Mollanij R, Johnston MG. Spinal and cranial contributions to total cerebrospinal fluid transport. Am. J. Physiol. 2001;281:R909–R916
  17. Knopf PM, Cserr HF, Nolan SC, Wu TY, Harling-Berg CJ. Physiology and immunology of lymphatic drainage of interstitial and cerebrospinal fluid from the brain. Neuropathol. Appl. Neurobiol. 1995;21:175–180
  18. Boulton M, Flessner M, Armstrong D, Mohamed R, Hay J, Johnston M. Contribution of extracranial lymphatics and arachnoid villi to the clearance of a CSF tracer in the rat. Am. J. Physiol. 1999;276:R818–R823
  19. Zenker W, Bankoul S, Braun JS. Morphological indications for considerable diffuse reabsorption of cerebrospinal fluid in spinal meninges particularly in the areas of meningeal funnels. Anat. Embryol. 1994;189:243–258
  20. Drayer BP, Rosenbaum AE. Metrizamide brain penetrance. Acta Radiol., Suppl. 1977;355:280–293
  21. Turner L. The structure of arachnoid granulations with observations on their physiological and pathological significance. Ann. R. Coll. Surg. Engl. 1961;29:237–264
  22. Pitre D, Zingales MF, Trevisan C. Urinary excretion of ipamidol following intrathecal administration. Neuroradiology. 1983;25:37–38
  23. McKinstry DN, Rommel AJ, Sugerman AA. Pharmacokinetics, metabolism, and excretion of iopamidol in healthy subjects. Invest. Radiol. 1984;19:171–174
  24. Sanchez NC, Tenofsky PL, Dort JM, Shen LY, Helmer SD, Smith RS. What is normal intra-abdominal pressure?. Am. Surgeon. 2001;67:243–248
  25. Sugerman HJ. Effects of increased intra-abdominal pressure in severe obesity. Surg. Clin. North Am. 2001;81:1063–1075
  26. Cutler RWP, Page L, Galicich J, Watters GV. Formation and absorption of cerebrospinal fluid in man. Brain. 1968;91:707–720
  27. Davson H, Hollingsworth G, Segal MB. The mechanism of drainage of the cerebrospinal fluid. Brain. 1970;93:665–678
  28. Halverson AL, Barrett WL, Iglesias AR, Lee WT, Garber SM, Sackier JM. Decreased cerebrospinal fluid absorption during abdominal insufflation. Surg. Endosc. 1999;13:797–800
  29. Le Gros Clark WE. On the Pacchionian bodies. J. Anat. 1920;55:40–48
  30. Veering B, Burm A, Vletter A, van den Hoeven R, Spierdijk J. The effect of age on systemic absorption and systemic disposition of bupivacaine after subarachnoid administration. Anesthesiology. 1991;74:250–257

PII: S0022-510X(02)00340-4

Journal of the Neurological Sciences
Volume 206, Issue 1 , Pages 85-90 , 15 January 2003

Article Tools

* Image Usage & Resolution